Be the first person to write a business review for Croudace Homes Group Limited

Cruttenden Partners is trying to root the evil out of money. The investment firm says it invests in companies that "help create a better world." It targets companies with strong management teams and offers services, such as financing, structuring, exiting, equity optimization. With a focus on early and late-stage investments, Cruttenden Partners' portfolio includes holdings in the financial, biomedical, and technology industries, such as SRS Sound Design (audio electronics), eGoose (financial advisory products for online traders), and PRISMedical Corporation (fluid therapies).

Cushman & Wakefield Sonnenblick Goldman is a global leader in real estate financial services, providing highly specialized debt structuring, debt and equity placement, hospitality financing and sales, note sales and associated advisory services. As a premier real estate investment banking firm, Cushman & Wakefield specialize in providing integrated capital solutions for all asset classes and are also a recognized industry leader in the financing and sale of hospitality and resort properties.By drawing on our integrated full service global platform C&WSG are able to assess our clients' current property operations and, at the same time, develop repositioning strategies that enhance asset value and maximize appeal to capital sources. With C&WSG focus on both the debt and equity markets, C&WSG clients the depth of insight and expertise needed to deliver creative, customized structuring solutions drawing from both traditional and non-traditional capital sources in a rapidly changing marketplace. Understanding the entire capital stack from equity and preferred equity to permanent, bridge, mezzanine and construction loans, C&WSG finance specialists tailor solutions to achieve optimal proceeds on the most attractive terms. From the conventional to cutting edge innovations, C&WSG long-standing record is unrivalled.

Founded in 1981 as Citicorp's European private equity arm, CVC carried out its own buyout in 1993 and is now owned by its management. It has about 20 offices around the world. CVC Capital Partners is in the business of making other businesses its business. The private equity investor specializes in buyouts of firms in the UK, the US, Western Europe, Asia, and Australia. Its portfolio of more than 50 companies consists mainly of retail, manufacturing, and service firms. Holdings include UK department store chain Debenhams, US-based luggage maker Samsonite, and Japan-based restaurant chain operator Skylark. It acquired a 47.5% stake in Pilot Travel Centers (now Pilot Flying J) in 2008.

De Novo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by De Novo investment success in selected medical device and biotechnology companies.With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. De Novo invest in all stages of enterprise development and growth – from early stage to late stage. De Novo unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.Eight exits have occurred in DNV I -- four IPOs: Favrille (NASDAQ: FVRL), Fox Hollow Technologies (NASDAQ: EVVV), Renovis (NASDAQ: RNVS), and SenoRx (NASDAQ: SENO) and four acquisitions: CryoVascular Systems (Boston Scientific), TriVascular (Boston Scientific), LuMend (Johnson and Johnson) and Microvention (Terumo). DNV II has had one exit to date – Hansen Medical (NASDAQ: HNSN).

Delphi Ventures was founded in 1988 and is based in Menlo Park, California. Delphi Ventures is a venture capital firm specializing in seed early stage, and PIPE investments. The firm seeks to invest in healthcare companies with a focus on medical devices and biotechnology. Within medical devices, it invests in cardiovascular medicine, orthopedics, gynecology, minimally invasive surgery, urology, neurovascular medicine, and next-generation diagnostics. Within biotechnology, the firm typically invests after a company has either generated early human clinical data or completed preclinical efficacy and toxicity studies. It prefers to invest in companies that are discovering new ways to treat life-threatening diseases and designing new devices to make surgery less traumatic and treatments more precise. The firm primarily invests between $500,000 million and $12 million.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.